文献速递肾癌与肾肿瘤

保留肾单位手术中缺血技术的系统综述与Meta分析:手术、肿瘤学及功能结局

Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.
PubMed 文献 · Eur Urol · 2018-10-13

该研究通过系统综述与Meta分析比较了冷缺血、热缺血和零缺血在保留肾单位手术中的手术、肿瘤学及功能结局。术后并发症、切缘阳性率及局部复发率有统计学差异但证据质量低;肾功能变化以冷缺血组log2 eGFR平均变化最大。结论认为现有证据受混杂因素影响,无法推荐任一缺血技术优于其他。

要点

  • 冷、热、零缺血的估计失血量无临床意义差异。
  • 术后并发症、切缘阳性率组间有差异,但证据质量低。
  • 现有证据无法推荐任一缺血技术优于其他。

核心结论

  • 现有证据受患者选择、手术技术及保留功能实质比例等混杂因素影响,无法推荐任一缺血技术优于其他。

主要发现

  • 冷缺血、热缺血和零缺血的估计失血量均值分别为215.5 ml(95%CI 154.2-276.8)、201.8 ml(95%CI 175.0-228.7)和261.2 ml(95%CI 171.0-351.3)。
  • 术后并发症发生率分别为冷缺血14.1%(95%CI 6.7-27.4)、热缺血11.1%(95%CI 10.0-12.3)和零缺血9.7%(95%CI 7.7-12.2),p<0.01。
  • 切缘阳性率分别为冷缺血4.8%(95%CI 1.9-10.9)、热缺血4.0%(95%CI 3.4-4.8)和零缺血5.6%(95%CI 3.1-9.8),p<0.01。
  • 局部复发率分别为热缺血3.2%(95%CI 1.9-5.2)和零缺血3.1%(95%CI 0.7-11.5),p<0.01。
  • 估计肾小球滤过率log2平均变化分别为冷缺血-1.37(95%CI -3.42至0.68)、热缺血-1.00(95%CI -2.04至0.03)和零缺血-0.71(95%CI -1.15至-0.27)ml/min。

临床怎么用

  • 临床决策应综合考虑患者选择、手术技术及保留功能实质比例等混杂因素,而非仅依据缺血技术选择。

局限性

  • 纳入研究多为回顾性,证据水平低,存在高选择偏倚和异质性,限制因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The optimal ischemia technique at partial nephrectomy (PN) for renal masses is yet to be determined. OBJECTIVE: To summarize and analyze the current evidence about surgical, oncological, and functional outcomes after different ischemia techniques (cold, warm, and zero ischemia) at PN. EVIDENCE ACQUISITION: A computerized systematic literature search was performed by using PubMed (MEDLINE) and Science Direct. Identification and selection of the studies were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) criteria. Outcomes of interest were estimated blood loss (EBL), overall complications, positive surgical margins, local tumor recurrence, and renal function preservation. Meta-analysis and forest-plot diagrams were performed. Overall pooled estimates, together with 95% confidence intervals (CIs), of the incidence of all parameters were obtained using a random effect model (RE-Model) on the log transformed means (MLN), proportion, or standardized mean change, as deemed appropriate. EVIDENCE SYNTHESIS: One hundred and fifty-six studies were included. No clinically meaningful differences were found in terms of EBL after cold (mean: 215.5; 95% CI: 154.2-276.8m), warm (mean: 201.8; 95% CI: 175.0-228.7ml), or zero (mean: 261.2; 95% CI: 171.0-351.3ml) ischemia technique. Overall, postoperative complications were recorded in 14.1% (95% CI: 6.7-27.4), 11.1% (95% CI: 10.0-12.3), and 9.7% (95% CI: 7.7-12.2) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Positive surgical margins were recorded in 4.8% (95% CI: 1.9-10.9), 4.0% (95% CI: 3.4-4.8), and 5.6% (95% CI: 3.1-9.8) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Local recurrence was recorded in 3.2% (95% CI: 1.9-5.2) and 3.1% (95% CI: 0.7-11.5) of patients after warm and zero ischemia (p<0.01), respectively. The log2 of estimated glomerular filtration ratio mean changes were-1.37 (95% CI:-3.42 to 0.68),-1.00 (-2.04 to 0.03), and-0.71 (-1.15 to-0.27) ml/min after cold, warm, and zero ischemia, respectively. Low level of evidence, retrospective nature of most of included studies, a high risk of selection bias, and heterogeneity within included studies limited the overall quality of the analysis. CONCLUSIONS: The effect of ischemia technique at PN is still debatable and subject to confounding by several factors, namely, patients' selection criteria, surgical technique used, and percentage of functional parenchyma spared during surgery. These confounders bias available evidence and were addressed by only a small part of available studies. Unfortunately, the overall quality of literature evidences and the high risk of selection bias limit the possibility of any causal interpretation about the relationship between the ischemia technique used and surgical, oncological, or functional outcomes. Thus, none of the available ischemia technique could be recommended over the other. PATIENT SUMMARY: The present analysis shows that none of the available ischemia techniques, namely, cold, warm, or zero ischemia, is universally superior to the others, and other factors play a role in the surgical outcome.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Greco F, Autorino R, Altieri V, et al. Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes. Eur Urol. 2018. PMID: 30327272. doi:10.1016/j.eururo.2018.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。